Table 3 Comparison of Prosigna® and SiNK™ score categories (2-tiered) in the test development cohort (n = 79).

From: Prosigna® breast cancer assay: histopathologic correlation, development, and assessment of size, nodal status, Ki-67 (SiNK™) index for breast cancer prognosis

 

Prosigna ≤ 40

Prosigna > 40

Total

SiNK ≤ 40

35

6

41

SiNK > 40

8

30

38

Total

43

36

79

  1. Score categorization concordant in 82.3% (65 of 79).
Back to article page